- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07585578
Multidimensional Dysfunction in Patients With Post-Intensive Care Syndrome in China
9. juni 2026 oppdatert av: Hongying Jiang, MD
Multidimensional Dysfunction in Patients With Post-Intensive Care Syndrome in China: A Multi-center Real-world Study
Over the past two decades, the rapid advancement of critical care medicine has significantly reduced short-term mortality among critically ill patients.
However, a growing number of intensive care unit (ICU) survivors experience persistent physical, cognitive, and psychological impairments after hospital discharge, a syndrome termed post-intensive care syndrome (PICS).
Although PICS has gained increasing attention in recent years, existing studies still have multiple limitations.
Given the continuously increasing number of ICU survivors in China and the marked heterogeneity in critical care delivery models across different regions and healthcare institutions, there is an urgent need for large-scale multicenter observational studies to systematically characterize the epidemiological features, multidimensional functional impairment profiles, and clinical impact of PICS in Chinese patients, thereby providing an evidence-based foundation for the development of a scientific post-ICU continuum of care.
Studieoversikt
Status
Rekruttering
Intervensjon / Behandling
Detaljert beskrivelse
This multi-center observational study aims to characterize the epidemiological profile and multidimensional functional impairments of Post-Intensive Care Syndrome (PICS) in ICU survivors across China.
The study will enroll approximately 800 eligible participants from four participating high-dependency units (HDUs) between January 2018 and January 2026.
Data on physical, cognitive, and psychological function will be collected using validated assessment tools including the MRC score, ICU Mobility Scale, CPAx, MMSE, S5Q, PHQ-9, GAD-7, PSQI, Barthel Index, and EQ-5D-5L.
The primary outcomes include the incidence of PICS and comorbidity patterns across multiple functional domains.
The secondary outcomes encompass functional status, quality of life, and risk factors for PICS.
Studietype
Observasjonsmessig
Registrering (Antatt)
800
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Jingyi Ge
- Telefonnummer: +861056981098
- E-post: ge_jingyi2020@163.com
Studer Kontakt Backup
- Navn: Hongying Jiang, MD
- Telefonnummer: +861056981098
- E-post: 6jhy@163.com
Studiesteder
-
-
Anhui
-
Huaibei, Anhui, Kina
- Har ikke rekruttert ennå
- Anhui Wanbei Rehabilitation Hospital
-
Ta kontakt med:
- Weiwei Ge
- Telefonnummer: 15956181729
- E-post: 1790183840@qq.com
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, Kina, 100043
- Rekruttering
- Beijing Rehabilitation Hospital, Capital Medical University, Beijing,China
-
Ta kontakt med:
- Hong ying Jiang
- Telefonnummer: +8601056981555
- E-post: 6jhy@163.com
-
-
Hunan
-
Hunan, Hunan, Kina, 410000
- Har ikke rekruttert ennå
- Hunan Rehabilitation Hospital
-
Ta kontakt med:
- Pan Li
- Telefonnummer: 86-18674765825
- E-post: 584703769@qq.com
-
-
Zhengzhou
-
Henan, Zhengzhou, Kina, 450007
- Har ikke rekruttert ennå
- Zhengzhou Central Hospital Affiliated to Zhengzhou University
-
Ta kontakt med:
- Yajing Wang
- Telefonnummer: 86-15515645380
- E-post: wangya568@163.com
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Prøvetakingsmetode
Sannsynlighetsprøve
Studiepopulasjon
This study is a multi-center, retrospective, observational cohort study that will enroll patients from four participating high-dependency units (HDUs) across China.
Patients transferred from general hospital ICUs to the participating HDUs between January 2018 and January 2026 will be screened.
Data will be sourced from medical records, nursing records, rehabilitation assessment records, and follow-up documentation from routine clinical care.
The anticipated total sample size is 800 participants.
Beskrivelse
Inclusion Criteria:
- Age ≥18 years
- First admission to ICU, with ICU length of stay ≥ 48 hours before transfer to HDU
- Complete the PICS assessment within 7 days after HDU admission
- Complete clinical data available (demographics, ICU-related information)
- Signed informed consent obtained from participants or legal guardians
Exclusion Criteria:
- Prior ICU admission
- Terminal illness or estimated life expectancy <6 months
- Participants or family members refuse to complete questionnaires
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
post-intensive care syndrome group
PICS patients who come from a general hospital ICU and are transferred to a participating HDU
|
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
MRC Sum Score for Muscle Strength
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
MRC (Medical Research Council) sum score assessing muscle strength.
Total score ranges from 0 (complete quadriplegia) to 60 (normal bilateral muscle strength).
Higher scores indicate better muscle strength.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
ICU Mobility Scale Score
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
ICU Mobility Scale (IMS) assessing mobility level in ICU patients.
Total score ranges from 0 (lying in bed, not active) to 10 (walking independently).
Higher scores indicate better mobility.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Chelsea Critical Care Physical Assessment Tool Score
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Chelsea Critical Care Physical Assessment Tool (CPAx) comprehensively evaluating physical function in ICU patients.
Total score ranges from 0 to 50.
Higher scores indicate better physical function.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Mini-Mental State Examination Score
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Mini-Mental State Examination (MMSE) assessing cognitive function.
Total score ranges from 0 to 30.
Higher scores indicate better cognitive function.
(Chinese validated version will be used.)
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
PHQ-9 Score for Depression
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Patient Health Questionnaire-9 (PHQ-9) assessing severity of depressive symptoms.
Total score ranges from 0 to 27 (0-4: none, 5-9: mild, 10-14: moderate, 15-19: moderately severe, 20-27: severe).
Higher scores indicate worse depression.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
GAD-7 Score for Anxiety
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Generalized Anxiety Disorder 7-item scale (GAD-7) assessing severity of anxiety symptoms.
Total score ranges from 0 to 21 (0-4: none, 5-9: mild, 10-14: moderate, 15-21: severe).
Higher scores indicate worse anxiety.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Pittsburgh Sleep Quality Index Global Score
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Pittsburgh Sleep Quality Index (PSQI) assessing sleep quality.
Global score ranges from 0 to 21.
Higher scores indicate worse sleep quality.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Brief Pain Inventory-9 Pain Severity Score
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Brief Pain Inventory-9 (BPI-9) pain severity score.
Total score ranges from 0 to 10. Higher scores indicate more severe pain.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Hospital Anxiety and Depression Scale Score for Family Caregivers
Tidsramme: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Hospital Anxiety and Depression Scale (HADS) assessing psychological status of family caregivers.
Each subscale (anxiety and depression) ranges from 0 to 21.
Higher scores indicate worse psychological distress.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
12. mai 2026
Primær fullføring (Antatt)
31. desember 2026
Studiet fullført (Antatt)
31. mai 2027
Datoer for studieregistrering
Først innsendt
1. mai 2026
Først innsendt som oppfylte QC-kriteriene
8. mai 2026
Først lagt ut (Faktiske)
14. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
11. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
9. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2026bkky-dzx-PICS
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .